Mode
Text Size
Log in / Sign up

Non-ST-elevation myocardial infarction

Part of Myocardial ischemia

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Non-ST-elevation myocardial infarction

3 trials tracked for Non-ST-elevation myocardial infarction: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 357 citations.

3Trials tracked
3Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 3
  1. Phase 4 Tailored Use of Tirofiban for Non-ST-elevation Acute Coronary Syndrome Patients Completed · 357 cited
  2. Phase 4 Brilinta Taiwan Post Approval Safety Study Completed
  3. Phase 4 Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Myocardial ischemia

Related studies from across the Myocardial ischemia family.

FFR-Guided PCI Deferral in STEMI Multivessel Disease Linked to Worse Long-Term Outcomes
Cardiology RCT
FFR-Guided PCI Deferral in STEMI Multivessel Disease Linked to Worse Long-Term Outcomes Treating multiple heart blockages may lower risk of death
In a DANAMI-3 PRIMULTI substudy, deferring PCI of non-culprit lesions with FFR > 0.80 in STEMI patients with multivessel disease was tied to…
New data shows that treating multiple blocked arteries during heart surgery can lower the risk of death and heart attacks for some patients.
Colchicine significantly reduces mean CRP levels in patients following myocardial infarction compared to placebo
Cardiology Meta-analysis
Colchicine significantly reduces mean CRP levels in patients following myocardial infarction compared to placebo Colchicine lowers inflammation levels in patients after heart attacks
This meta-analysis of randomized, placebo-controlled trials involving 3384 patients found that colchicine significantly decreased mean CRP l…
A new look at clinical data shows that daily colchicine can lower a key marker of inflammation in people who have recently suffered a heart …
Impella CP improves survival in selected cardiogenic shock patients while routine early VA-ECMO lacks clear benefit
Rheumatology Meta-analysis
Impella CP improves survival in selected cardiogenic shock patients while routine early VA-ECMO lacks clear benefit New data clarifies the role of heart pumps in shock
This narrative review examines the use of VA-ECMO and microaxial-pump strategies in patients with cardiogenic shock and ST-elevation myocard…
New research looks at how heart pumps and bypass machines help patients with severe heart damage after a heart attack.
Individualized mechanical circulatory support is necessary as increased hemodynamic support does not uniformly improve survival
Cardiology Sys. Review
Individualized mechanical circulatory support is necessary as increased hemodynamic support does not uniformly improve survival Mechanical Support for Cardiogenic Shock Does Not Uniformly Improve Survival
This mini review examines the role of short-term mechanical circulatory support (MCS) in patients with cardiogenic shock, including those wi…
Newer reviews suggest that while mechanical support helps heart function, it does not always lead to better survival rates for patients in c…
Qili Qiangxin plus conventional medicine improves surrogate markers in heart failure after myocardial infarction
Drug Pipeline Meta-analysis
Qili Qiangxin plus conventional medicine improves surrogate markers in heart failure after myocardial infarction Qili Qiangxin May Improve Heart Function After Heart Attack
This meta-analysis of 1391 patients found that Qili Qiangxin combined with conventional Western medicine led to greater reductions in NT-pro…
Adding Qili Qiangxin to standard medicine may improve heart function and quality of life for patients following a heart attack.
OMI/NOMI approach increases immediate invasive management to 45.4% compared to 13.6% in myocardial infarction
Cardiology RCT
OMI/NOMI approach increases immediate invasive management to 45.4% compared to 13.6% in myocardial infarction New approach helps doctors find blocked heart arteries more quickly during emergencies
This multicenter randomized controlled trial substudy evaluated 4398 adult patients with myocardial infarction to compare the OMI/NOMI appro…
A new way of looking at heart attacks helps doctors find blocked arteries faster, leading to quicker treatment for patients in need.
NLRP3 inflammasome activation serves as a molecular bridge between myocardial infarction and depression
Cardiology Sys. Review
NLRP3 inflammasome activation serves as a molecular bridge between myocardial infarction and depression Inflammasome Activation Links Heart Attacks and Depression
This systematic review examines the role of the NLRP3 inflammasome in the link between myocardial infarction and depression. The authors con…
A specific inflammatory pathway called NLRP3 may act as a bridge between heart attacks and depression, potentially offering a new target for…
Beta-blocker therapy shows no significant reduction in primary composite outcomes for patients with LVEF ≥ 40%
Cardiology Meta-analysis
Beta-blocker therapy shows no significant reduction in primary composite outcomes for patients with LVEF ≥ 40% Beta-blocker therapy shows mixed results for heart attack patients
This meta-analysis of 18,504 patients with acute myocardial infarction and LVEF ≥ 40% found no significant reduction in the primary composit…
New data suggests beta-blockers may only show a significant benefit for heart attack patients with specific levels of heart muscle function.
Naoxintong Supplementation Reduces Heart Failure Risk Following Acute Myocardial Infarction
Cardiology RCT
Naoxintong Supplementation Reduces Heart Failure Risk Following Acute Myocardial Infarction New treatment may lower heart failure risk after heart attack
A randomized trial suggests that adding Naoxintong to standard therapy significantly reduces heart failure incidence and MACE rates post-AMI…
A new study shows that adding a herbal formula to standard care can significantly reduce heart failure risk for patients after a heart attac…
Clinical signs, imaging, and biomarkers facilitate risk stratification for cardiac rupture in myocardial infarction
Cardiology Sys. Review
Clinical signs, imaging, and biomarkers facilitate risk stratification for cardiac rupture in myocardial infarction New tools help doctors predict life-threatening heart ruptures after heart attacks
This mini review synthesizes clinical warning signs, point-of-care imaging, and biomarker trajectories to stratify risk of cardiac rupture i…
Doctors are developing a new four-step plan to spot early warning signs of heart rupture, a condition where the heart muscle tears during a …
Intravenous nicorandil did not significantly reduce primary composite outcomes in patients with STEMI
Cardiology RCT
Intravenous nicorandil did not significantly reduce primary composite outcomes in patients with STEMI Trial shows intravenous nicorandil does not improve heart attack outcomes
This randomized controlled trial of 1,503 patients with STEMI found no significant difference in the primary composite outcome between intra…
A large trial of over 1,500 patients found that the drug nicorandil did not improve primary outcomes for those with a heart attack.
DeepSeek AI generates guideline-conforming exercise prescriptions for myocardial infarction, heart failure, and atrial fibrillation
Physical Medicine & Rehab Guideline
DeepSeek AI generates guideline-conforming exercise prescriptions for myocardial infarction, heart failure, and atrial fibrillation AI Shows Potential for Creating Heart Health Exercise Plans
This guideline-based simulation study evaluates the use of the DeepSeek model to generate exercise prescriptions for patients with myocardia…
A simulation study shows that AI can generate safe, guideline-based exercise plans for patients with heart conditions like heart failure and…